Landis John B.
CIK: 0001477283
Associated companies
Transaction History
| EYPT | ▲ Buy | Option Exercise | 10,000 | $0 | 1/5/2025 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 3,000 | $0 | 2/9/2023 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 2,500 | $0 | 2/9/2022 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 10,000 | $0 | 1/5/2025 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 3,000 | $0 | 2/9/2023 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 2,500 | $0 | 2/9/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Yahoo article highlights EYPT as a potential portfolio addition
A recent Yahoo article discussed EyePoint Inc. (EYPT) and listed reasons why the stock could be considered for a portfolio. The piece referenced the company's analyst consensus target of $25.91 and its 52‑week range of $2.93 to $19.11. The article’s positive tone adds to current market conversation around the stock.
Yahoo article highlights EYPT as a potential portfolio addition. A recent Yahoo article discussed EyePoint Inc. (EYPT) and listed reasons why the stock could be considered for a portfolio. The piece referenced the company's analyst consensus target of $25.91 and its 52‑week range of $2.93 to $19.11. The article’s positive tone adds to current market conversation around the stock.